Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Johnson and Johnson
Baxter
Boehringer Ingelheim
Merck

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Benzoylecgonine

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Benzoylecgonine?

Benzoylecgonine is an investigational drug.

There have been 18 clinical trials for Benzoylecgonine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2011.

The most common disease conditions in clinical trials are Cocaine-Related Disorders, Renal Insufficiency, and Substance-Related Disorders. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), University of Pennsylvania, and Cincinnati MDRU.

There are six hundred and twenty-six US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Benzoylecgonine
TitleSponsorPhase
Trial Of NS2359 For The Treatment of Cocaine DependenceSanionaPhase 2
Trial Of NS2359 For The Treatment of Cocaine DependenceThe Dana FoundationPhase 2
Trial Of NS2359 For The Treatment of Cocaine DependenceUniversity of PennsylvaniaPhase 2

See all Benzoylecgonine clinical trials

Clinical Trial Summary for Benzoylecgonine

Top disease conditions for Benzoylecgonine
Top clinical trial sponsors for Benzoylecgonine

See all Benzoylecgonine clinical trials

US Patents for Benzoylecgonine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Benzoylecgonine   Start Trial Devices and methods for continuous analyte monitoring DexCom, Inc. (San Diego, CA)   Start Trial
Benzoylecgonine   Start Trial Devices and methods for continuous analyte monitoring DexCom, Inc. (San Diego, CA)   Start Trial
Benzoylecgonine   Start Trial Indicator and analytics for sensor insertion in a continuous analyte monitoring system and related methods DexCom, Inc. (San Diego, CA)   Start Trial
Benzoylecgonine   Start Trial Advanced analyte sensor calibration and error detection DexCom, Inc. (San Diego, CA)   Start Trial
Benzoylecgonine   Start Trial Tamper-resistant pharmaceutical compositions of opioids and other drugs COLLEGIUM PHARMACEUTICAL, INC. (Canton, MA)   Start Trial
Benzoylecgonine   Start Trial Pharmaceutical compositions and methods of using the same GENUS LIFESCIENCES INC. (Allentown, PA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Benzoylecgonine

Drugname Country Document Number Estimated Expiration Related US Patent
Benzoylecgonine European Patent Office 3069279 2033-11-14   Start Trial
Benzoylecgonine World Intellectual Property Organization (WIPO) 2015073459 2033-11-14   Start Trial
Benzoylecgonine European Patent Office 3069279 2033-11-14   Start Trial
Benzoylecgonine World Intellectual Property Organization (WIPO) 2015073459 2033-11-14   Start Trial
Benzoylecgonine European Patent Office 3068302 2033-11-14   Start Trial
Benzoylecgonine World Intellectual Property Organization (WIPO) 2015073588 2033-11-14   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
McKinsey
Johnson and Johnson
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.